A double-blind placebo-controlled evaluation of the acute effects of sildenafil citrate (VIAGRA) on visual function in subjects with early-stage age-related macular degeneration

American Journal of Ophthalmology

Volumn 133, Issue 5, 2002, Pages 665-672

  Birch, David G ^a   Toler, Steven M ^b   Swanson, William H ^c   Fish, Gary E ^a   Laties, Alan M ^d  

^a RETINA FOUNDATION OF THE SOUTHWEST   (United States)

^b PFIZER INC   (United States)

^c STATE UNIVERSITY OF NEW YORK   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG METABOLITE; PLACEBO; SILDENAFIL; UK 103 320; UNCLASSIFIED DRUG;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COLOR DISCRIMINATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG SAFETY; DRUG TOLERABILITY; DRUSEN; FLUSHING; HEADACHE; HUMAN; MALE; PERIMETRY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETINA MACULA AGE RELATED DEGENERATION; RHINITIS; TREATMENT OUTCOME; VISION; VISUAL ACUITY; VISUAL IMPAIRMENT;

3',5'-CYCLIC-GMP PHOSPHODIESTERASE; AGED; AGED, 80 AND OVER; COLOR PERCEPTION; COLOR PERCEPTION TESTS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG EVALUATION; HUMANS; MACULAR DEGENERATION; MALE; MIDDLE AGED; PERIMETRY; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; PROSPECTIVE STUDIES; SAFETY; VISUAL ACUITY; VISUAL FIELDS;

EID: 0036248385     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(02)01338-7     Document Type: Article

References (22)

1. Sildenafil (Viagra) and ophthalmology
2. Sildenafil, a novel inhibitor of phosphodiesterase type 5 in human corpus cavernosum smooth muscle cells
3. Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes
4. Visual function testing in patients and healthy volunteers receiving VIAGRA
5. The effects of long-term sildenafil treatment on ocular safety in patients with erectile dysfunction
6. Clinical safety of oral sildenafil citrate (VIAGRA) in the treatment of erectile dysfunction
7. Short time influences of sildenafil on visual function
8. Retinal side-effects of sildenafil
9. Acute effects of sildenafil on the electroretinogram and multifocal electroretinogram
10. Age-related macular degeneration
11. A quantitative scoring technique for panel tests of color vision
12. A Guide for the design of road traffic lights
13. The photo-stress recovery test in the clinical assessment of visual function
14. Three-year update of sildenafil citrate (Viagra) efficacy and safety
15. No clinically important effects on intraocular pressure after short-term administration of sildenafil citrate (VIAGRA)
16. Acute effects of sildenafil citrate (Viagra) on intraocular pressure in open-angle glaucoma
17. Effect of sildenafil citrate (Viagra) on the ocular circulation
18. Sildenafil and ocular perfusion
19. Anterior ischemic optic neuropathy associated with Viagra
20. Sildenafil (Viagra) associated anterior ischemic optic neuropathy
21. Viagra®-associated ischemic optic neuropathy. Response